Trial · NCT07899099
Mecapegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Advanced Breast Cancer
NCT07899099, Recruiting, Zheng Yabing
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Mecapegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Advanced Breast Cancer. Trials, record NCT07899099. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07899099
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Mecapegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Advanced Breast Cancer
- NCT number
- NCT07899099
- Status
- Recruiting
- Enrollment
- 200 participants, estimated
- Lead sponsor
- Zheng Yabing
- Conditions
- Breast Cancer, Chemotherapy-induced Neutropenia
- Interventions
- No Prophylactic G-CSF, Short-acting G-CSF, Long-acting G-CSF
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Use of Mecapegfilgrastim for Primary and Secondary Prophylaxis | From enrollment through completion of follow-up, assessed up to 12 months. | Proportion of participants receiving mecapegfilgrastim as primary prophylaxis or secondary prophylaxis during palliative systemic anticancer therapy. |
| Secondary | Incidence of Febrile Neutropenia | From treatment initiation through 12 months. | Proportion of participants who develop febrile neutropenia during systemic anticancer treatment. |
| Secondary | Patient-Reported Quality of Life | At baseline and during follow-up, assessed up to 12 months. | Quality of life assessed using the Chinese versions of the EORTC QLQ-C30 |
| Secondary | Adherence to Mecapegfilgrastim Prophylaxis | From treatment initiation through 12 months. | Proportion of participants who receive prophylaxis as planned, including reasons for refusal or discontinuation. |
| Secondary | Patient-Reported Quality of Life | At baseline and during follow-up, assessed up to 12 months. | Quality of life assessed using the Chinese versions of the EORTC QLQ-BR45 questionnaires. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07899099
GET https://conductscience.org/api/trials/v1/NCT07899099/registered